Author

Antonio Rodríguez 1

1 H Clinico de Salamanca,Salamanca,Spain

Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Pilar Nos Mateu, Eva Iglesias, Isabel Vera, Antonio López-San Román, Jordi Guardiola, Carlos Taxonera, Miguel Mínguez, Mariló Martin-Arranz, Luisa de Castro, Sabino Riestra, Montserrat Rivero, Esther García-Planella, Xavier Calvet, Santiago García-López, Montserrat Andre

LONG-TERM OUTCOMES OF ADALIMUMAB THERAPY IN ULCERATIVE COLITIS PATIENTS BY PRIOR ANTI-TNF EXPOSURE

Carlos Taxonera, Eva Iglesias, Jose Fernando Muñoz Nuñez, Marta Calvo, Manuel Barreiro de Acosta, David Busquets, Xavier Calvet Calvo, Antonio Rodríguez, Ramón Pajares, Javier Gisbert, Pilar López Serrano, José Lázaro Pérez-Calle, Angel Ponferrada, Cristobal de la Coba, Fernando Bermejo, Maria Chaparro Sanchez, Cristina Alb

COMPARATIVE STUDY OF ELECTRICAL AND RHEOLOGICAL PROPERTIES OF DIFFERENT SOLUTIONS TO PERFORM SUBMUCOSAL INJECTION

Ignacio Bon, Vicente Lorenzo-Zúñiga, Vicente Moreno de Vega, Antonio Rodríguez, Napoleón David De la Ossa, Ingrid Marin Fernandez, Jaume Boix, Ramon Bartolí

METHOTREXATE AFTER ANTI-TNF-α FAILURE IN CROHN'S DISEASE: A RETROSPECTIVE SERIES FROM THE ENEIDA REGISTRY. TEACHING AN OLD DOG NEW TRICKS?

Francisco Mesonero, Jesus Castro Poceiro, Elena Ricart, Jose Manuel Benitez, Blau Camps Aler, Jordi Guardiola, Marisa Iborra, Alicia López-García, Paola Francesca Torres Rodríguez, María Esteve, Joan Tosca, Federico Bertoletti, Pedro Almela, Xavier Calvet, Maria Isabel Vera, Luis Bujanda, Fernando Gomollón Garcia, Cristina

Item 1 - 4 / 4
1
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK